These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10839625)

  • 1. Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain.
    Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
    J Protein Chem; 1999 Nov; 18(8):881-4. PubMed ID: 10839625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway.
    Chie L; Amar S; Kung HF; Lin MC; Chen H; Chung DL; Adler V; Ronai Z; Friedman FK; Robinson RC; Kovac C; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
    Cancer Chemother Pharmacol; 2000; 45(6):441-9. PubMed ID: 10854130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the site of inhibition of mitogenic signaling by oncogenic ras-p21 by a ras effector peptide.
    Chie L; Friedman FK; Kung HF; Lin MC; Chung D; Pincus MR
    J Protein Chem; 2002 Jul; 21(5):367-70. PubMed ID: 12206511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes.
    Ranginwale M; Smith S; Flom J; Chie L; Kanovsky M; Chung D; Friedman FK; Robinson RC; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
    Exp Cell Res; 2001 Sep; 269(1):162-9. PubMed ID: 11525649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation.
    Kovac C; Clie L; Morin J; Friedman FK; Robinson R; Chung DL; Kanovsky M; Flom J; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
    Cancer Chemother Pharmacol; 2001 Jul; 48(1):9-14. PubMed ID: 11488531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations. Selective inhibition of oncogenic ras-p21.
    Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
    J Protein Chem; 1999 Nov; 18(8):875-9. PubMed ID: 10839624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
    Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
    Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification, using molecular dynamics, of an effector domain of the ras-binding domain of the raf-p74 protein that is uniquely involved in oncogenic ras-p21 signaling.
    Chen JM; Rijhwani K; Friedman FK; Hyde MJ; Pincus MR
    J Protein Chem; 2000 Oct; 19(7):545-51. PubMed ID: 11233167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic and activated wild-type ras-p21 proteins induce different isoforms of protein kinase C in mitogenic signal transduction.
    Chie L; Qu Y; Chung D; Boutjdir M; Pincus MR
    J Protein Chem; 2003 Nov; 22(7-8):625-9. PubMed ID: 14714729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ras-induced oocyte maturation by peptides from ras-p21 and GTPase activating protein (GAP) identified as being effector domains from molecular dynamics calculations.
    Friedman FK; Chie L; Chung D; Robinson R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
    J Protein Chem; 2002 Jul; 21(5):361-6. PubMed ID: 12206510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
    Adler V; Bowne W; Michl J; Sookraj KA; Ikram K; Pestka S; Izotova L; Zenilman M; Friedman FK; Qu Y; Pincus MR
    Ann Clin Lab Sci; 2008; 38(1):47-56. PubMed ID: 18316782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21.
    Chie L; Adler V; Friedman FK; Chung D; Pincus MR
    Protein J; 2004 Apr; 23(3):235-8. PubMed ID: 15200055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agents.
    Amar S; Glozman A; Chung D; Adler V; Ronai Z; Friedman FK; Robinson R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
    Cancer Chemother Pharmacol; 1997; 41(1):79-85. PubMed ID: 9443618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual-specificity kinases, TOPK and DYRK1A, are critical for oocyte maturation induced by wild-type--but not by oncogenic--ras-p21 protein.
    Qu Y; Adler V; Izotova L; Pestka S; Bowne W; Michl J; Boutjdir M; Friedman FK; Pincus MR
    Front Biosci; 2007 Sep; 12():5089-97. PubMed ID: 17569632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of inhibition of ras-p21 signal transduction by peptides from GTPase activating protein (GAP) and the son-of sevenless (SOS) ras-specific guanine nucleotide exchange protein.
    Chie L; Chung D; Pincus MR
    Protein J; 2005 May; 24(4):253-8. PubMed ID: 16283548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two dual specificity kinases are preferentially induced by wild-type rather than by oncogenic RAS-P21 in Xenopus oocytes.
    Qu Y; Adler V; Chu T; Platica O; Michl J; Pestka S; Izotova L; Boutjdir M; Pincus MR
    Front Biosci; 2006 Sep; 11():2420-7. PubMed ID: 16720323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase.
    Villafania A; Anwar K; Amar S; Chie L; Way D; Chung DL; Adler V; Ronai Z; Brandt-Rauf PW; Yamaizumii Z; Kung HF; Pincus MR
    Ann Clin Lab Sci; 2000 Jan; 30(1):57-64. PubMed ID: 10678584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the ras-binding domain of the raf-p74 protein, identified from molecular dynamics calculations.
    Chung D; Amar S; Glozman A; Chen JM; Friedman FK; Robinson R; Monaco R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
    J Protein Chem; 1997 Aug; 16(6):631-5. PubMed ID: 9263125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti- ras peptide.
    Way D; Smith S; Sivendran S; Chie L; Kanovsky M; Brandt-Rauf PW; Chung DL; Michl J; Pincus MR
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):429-37. PubMed ID: 12107546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protein methyl transferase, PRMT5, selectively blocks oncogenic ras-p21 mitogenic signal transduction.
    Chie L; Cook JR; Chung D; Hoffmann R; Yang Z; Kim Y; Pestka S; Pincus MR
    Ann Clin Lab Sci; 2003; 33(2):200-7. PubMed ID: 12817625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.